Last reviewed · How we verify
NCT06031064
External Validation of a Microscopic Colitis Clinical Scoring System in Patients With Chronic Watery Diarrhoea
trial in Microscopic Colitis in 200 participants. Status unknown.
1 February 2024
Quick facts
| Lead sponsor | Hospital Mutua de Terrassa |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 15 May 2022 |
| Primary completion | 1 February 2024 |
| Estimated completion | 1 February 2024 |
| Sites | 1 location across Spain |
Conditions studied
- Microscopic Colitis — all drugs for Microscopic Colitis →
Sponsor
Hospital Mutua de Terrassa
Who can join
40 and older, any sex, with Microscopic Colitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Chronic watery diarrhoea is a very common problem in the population and most of these patients will be referred for colonoscopy. If no macroscopic findings are observed during colonoscopy to justify the diarrhoea, serial colonic biopsies will be taken to rule out Microscopic Colitis (MC). However, it has been estimated that only 10-15% of these patients will be diagnosed with MC after colonoscopy. Therefore, about 80% of the biopsies collected and analysed will not be useful to establish a diagnosis, considerably increasing costs. To predict the risk of developing MC, a new promising clinical scoring system has been recently developed. This score will be useful in the diagnostic work-up of chronic watery diarrhoea to prioritize colonoscopy with stepwise colonic biopsies in patients with a positive highly specific score for MC. In cases with a negative score, colonoscopy plus biopsies should be performed only if other diagnostic tests are negative. The aim of this current study is to externally validate the new scoring system to predict MC in patients with chronic watery diarrhoea.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06031064
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Microscopic Colitis
Currently open trials in the same condition.
- NCT07156175 — A Study to Investigate the Efficacy and Safety of SAR444336 in Adults With Microscopic Colitis in Clinical Remission · Phase 2 · recruiting
- NCT06530836 — Chronic Diarrhea Owing to Underlying Microscopic Colitis · active not recruiting
Other Hospital Mutua de Terrassa trials
Trials by the same sponsor.
- NCT07070596 — Study of the NATURal History, Epidemiological, Clinical, Diagnostic and Therapeutic Aspects of CELiac Disease and Non-ce · recruiting
- NCT06404931 — Transvaginal Human Acellular Dermal Matrix for Prolapse Treatment · Phase 2 · recruiting
- NCT05919433 — Detection Program for Patients With Primary Biliary Cholangitis Lost in the System · recruiting
- NCT06036680 — Long-term Study of Endoscopic Treatment of Stenosis in Crohn´s Disease · unknown
- NCT05708820 — Online Education Programme for People With Type 1 Diabetes and Suboptimal Metabolic Control · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06031064 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Mutua de Terrassa
- Last refreshed: 11 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06031064.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing